Commentary

Wisconsin bioscience companies have positioned themselves as national and international leaders in a range of industries - from molecular diagnostics to medical imaging. In this guest column, Jim Leonhart, executive vice president of the Wisconsin Biotechnology and Medical Device Association, explains how these businesses are...

States must have a good network infrastructure to build a 21st Century knowledge economy, writes columnist James Carlini. In this edition of Carlini's Comments, he warns that states which create and foster a positive platform for network infrastructure are going to capture businesses from the...

The Abbott-Thailand patent saga is more than just a dispute between an American company and a foreign government, according to columnist and physician Ogan Gurel. At stake is what former Wisconsin governor and HHS Secretary Tommy Thompson calls “the balancing act between innovation and access.”...

Are American technology and life-science businesses getting a bum rap when they take advantage of the H-1B specialty worker program? Attorney Grant Sovern thinks so, and in this guest column he defends the program and urges Congress to lift the cap on the number of...

How do we excite more students about careers in the STEM disciplines? That's a question many educators and employers have been asking lately. In his latest Inside Wisconsin column, Tom Still recognizes Timothy Jump, an educator who may have the answer. Jump, who recently led...

Recent changes in patent law demand that patentees making unsolicited licensing proposals change their tactics and plan their strategy before mailing demand letters, according to attorney Charles Crueger of Michael Best & Friedrich. He writes that any company that doesn't take these new rules of...

In the battle of brand images, the theme-based city is becoming dominant in certain areas. In this edition of Name Bank, columnist Naseem Javed notes that a city name is not necessarily the most important thing in creating a stronger brand. That lies in building...

After extolling the virtues of the Illinois-Wisconsin piece of the so-called Mega-Metro Center complex, columnist James Carlini heard from readers who wondered where Indiana fits in. The Hoosier state may very well be a thriving part of this connection, he writes, but it has a...

Until recently, the 2007 stock market performance was nothing to write home about, with one notable exception, according to Yer Biotech Blues columnist Michael Rosen. Midwestern biotech stocks did so well that 18 stocks (72 percent) out of a basket of the top 25 stocks...

Is there a method to the methodology madness? Columnist and information technology strategist Patrick Gray says even the best methodology can't save a project beset with poor leadership and poor project management. Methodologies are important to an extent, he writes, but they pale in comparison...